Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;56(4):1916-20.
doi: 10.1128/AAC.05325-11. Epub 2012 Jan 17.

MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus

Affiliations

MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus

Christine Seah et al. Antimicrob Agents Chemother. 2012 Apr.

Abstract

Mupirocin is a topical antibiotic used for the treatment of skin infections and the eradication of methicillin-resistant Staphylococcus aureus carriage. It inhibits bacterial protein synthesis by interfering with isoleucyl-tRNA synthetase activity. High-level mupirocin resistance (MIC of ≥ 512 μg/ml) is mediated by the expression of mupA (ileS2), which encodes an alternate isoleucyl-tRNA synthetase. In this study, we describe high-level mupirocin resistance mediated by a novel locus, mupB. The mupB gene (3,102 bp) shares 65.5% sequence identity with mupA but only 45.5% identity with ileS. The deduced MupB protein shares 58.1% identity (72.3% similarity) and 25.4% identity (41.8% similarity) with MupA and IleS, respectively. Despite this limited homology, MupB contains conserved motifs found in class I tRNA synthetases. Attempts to transfer high-level mupirocin resistance via conjugation or transformation (using plasmid extracts from an mupB-containing strain) were unsuccessful. However, by cloning the mupB gene into a shuttle vector, it was possible to transfer the resistance phenotype to susceptible S. aureus by electroporation, proving that mupB was responsible for the high-level mupirocin resistance. Further studies need to be done to determine the prevalence of mupB and to understand risk factors and outcomes associated with resistance mediated by this gene.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Nucleotide sequence of the mupB gene and its promoter region. Start and stop codons are indicated in bold, and protein translation is reported above the DNA sequence. A putative promoter region is indicated, including the −35 box (TTGAAA), the −10 box (ATTAAT), and a ribosome binding site (RBS) (AAGGAAG). Conserved motifs found in class I tRNA synthetases are highlighted in gray.
Fig 2
Fig 2
Southern blot analysis. (A) Plasmids extracted from strains MUP87 (mupB positive) and GP135 (mupA positive) and digested with HindIII (lanes 1 and 3) or left undigested (lanes 2 and 4). Autoradiograms of gel A hybridized with mupB (B), mupA (C), and blaZ (D) probes are shown. Arrows indicate positive bands for the different probes. Lane λ-H, λ phage-HindIII molecular size marker (in kb).

Similar articles

Cited by

References

    1. Antonio M, Mcferran N, Pallen MJ. 2002. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:438–442 - PMC - PubMed
    1. Charpentier E, et al. 2004. Novel cassette-based shuttle vector system for Gram-positive bacteria. Appl. Environ. Microbiol. 70:6076–6085 - PMC - PubMed
    1. Christianson S, Golding GR, Campbell J, Mulvey MR. 2007. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45:1904–1911 - PMC - PubMed
    1. Clinical and Laboratory Standards Institute 2011. Performance standards for antimicrobial susceptibility testing. 21st informational supplement. M100-S21. CLSI, Wayne, PA
    1. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss, and rearrangement. PLoS One 5:e11147. - PMC - PubMed

Publication types

MeSH terms